 The alpha 4 integrin on inflammatory cells interacts with these adhesion molecules to allow for migration.Integrin receptor antagonists block the interaction and prevent the migration of inflammatory cells to disease sites.Natalizumab is a humanized IgG4 monoclonal antibody that inhibits the alpha 4 integrin.